Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Past Issues
    • Accepted Articles
    • Email Alerts
    • RSS
    • Terms of Use
  • About PDA JPST
    • JPST Editors and Editorial Board
    • About/Vision/Mission
    • Paper of the Year
  • Author & Reviewer Resources
    • Author Resources / Submit
    • Reviewer Resources
  • JPST Access and Subscriptions
    • PDA Members
    • Institutional Subscriptions
    • Nonmember Access
  • Support
    • Join PDA
    • Contact
    • Feedback
    • Advertising
    • CiteTrack
  • .
    • Visit PDA
    • PDA Letter
    • Technical Reports
    • news uPDATe
    • Bookstore

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
PDA Journal of Pharmaceutical Science and Technology
  • .
    • Visit PDA
    • PDA Letter
    • Technical Reports
    • news uPDATe
    • Bookstore
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
PDA Journal of Pharmaceutical Science and Technology

Advanced Search

  • Home
  • Content
    • Current Issue
    • Past Issues
    • Accepted Articles
    • Email Alerts
    • RSS
    • Terms of Use
  • About PDA JPST
    • JPST Editors and Editorial Board
    • About/Vision/Mission
    • Paper of the Year
  • Author & Reviewer Resources
    • Author Resources / Submit
    • Reviewer Resources
  • JPST Access and Subscriptions
    • PDA Members
    • Institutional Subscriptions
    • Nonmember Access
  • Support
    • Join PDA
    • Contact
    • Feedback
    • Advertising
    • CiteTrack
  • Follow pda on Twitter
  • Visit PDA on LinkedIn
  • Visit pda on Facebook
Article CommentaryCommentary

Considerations for the Validation of Non-CFU Based Bio-Fluorescent Particle Counting Technologies

Cynthia Martindale, Caroline Dreyer, Cedric Joossen, Joanny Salvas, Kim Perkins, Mike Dingle, Petra Merker, Philip Villari, Tony Cundell, Margit Franz-Riethdorf and Patrick Hutchins
PDA Journal of Pharmaceutical Science and Technology November 2025, 79 (6) 694-706; DOI: https://doi.org/10.5731/pdajpst.2024-003036.1
Cynthia Martindale
1Applied Rapid Microbiology Specialists, Ltd.;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Caroline Dreyer
2Novo Nordisk A/S, Novo Alle, DK-2880 Bagsvaerd, Denmark;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cedric Joossen
3Janssen Pharmaceutica NV, a Johnson & Johnson company, Turnhoutseweg 30, 2340 Beerse, Belgium;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joanny Salvas
4Pfizer, Kirkland, QC, Canada;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kim Perkins
5Mettler-Toledo Thornton, Inc., 900 Middlesex Turnpike #8, Billerica, MA 01821;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mike Dingle
6TSI Incorporated, 500 Cardigan Road, Shoreview, MN 55126;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Petra Merker
7Bayer AG, Müllerstr. 178, D-13353 Berlin, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Philip Villari
8PO Box 60115, King of Prussia, PA 19406;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tony Cundell
9Microbiological Consulting, LLC., Rye, NY 10580;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Margit Franz-Riethdorf
10Postfach 55 26, 97005 Würzburg, Germany; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: margitm3{at}icloud.com
Patrick Hutchins
11TSI Incorporated, 500 Cardigan Road, Shoreview, MN 55126
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • References
  • Info & Metrics
  • PDF
Loading

Abstract

The use of bio-fluorescent particle counting technologies as a rapid, alternative method to monitor microbial contamination in water and clean room air samples has been of interest to the pharmaceutical industry for several years. These technologies are a non-growth-based method that use the detection of particle scatter and intrinsic fluorescence to categorize detected particles as biologic or non-biologic. As a result, the systems report in a unit of measure not equivalent to the colony-forming unit. Although guidance on the validation of alternative microbial methods is available, significant challenges can exist when validating non-growth-based alternative methods compared to the growth-based compendial method. Collaborators in the Modern Microbial Methods (M3) industry working group provide thoughts and recommendations on a method validation pathway for the non-growth-based bio-fluorescent particle counting technology. Technology-specific recommendations on the primary and secondary validation are provided with considerations on the applicability of individual validation parameters and associated acceptance criteria for this emerging technology that does not rely on the colony-forming unit.

  • Alternative rapid microbial method (ARMM)
  • Bio-fluorescent particle counting (BFPC)
  • Microbiology
  • USP <1223>
  • Validation
  • © PDA, Inc. 2025
View Full Text

PDA members receive access to all articles published in the current year and previous volume year. Institutional subscribers received access to all content. Log in below to receive access to this article if you are either of these.  

If you are neither or you are a PDA member trying to access an article outside of your membership license, then you must purchase access to this article (below). If you do not have a username or password for JPST, you will be required to create an account prior to purchasing. 

Full issue PDFs are for PDA members only.

Note to pda.org users

The PDA and PDA bookstore websites (www.pda.org and www.pda.org/bookstore) are separate websites from the PDA JPST website. When you first join PDA, your initial UserID and Password are sent to HighWirePress to create your PDA JPST account. Subsequent UserrID and Password changes required at the PDA websites will not pass on to PDA JPST and vice versa. If you forget your PDA JPST UserID and/or Password, you can request help to retrieve UserID and reset Password below.

Log in using your username and password

Forgot your user name or password?

Log in through your institution

You may be able to gain access using your login credentials for your institution. Contact your library if you do not have a username and password.
If your organization uses OpenAthens, you can log in using your OpenAthens username and password. To check if your institution is supported, please see this list. Contact your library for more details.

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.

patientACCESS

patientACCESS - Patients desiring access to articles

Full issue PDFs are for PDA members only. You can join PDA at www.pda.org. 

PreviousNext
Back to top

In This Issue

PDA Journal of Pharmaceutical Science and Technology: 79 (6)
PDA Journal of Pharmaceutical Science and Technology
Vol. 79, Issue 6
November/December 2025
  • Table of Contents
  • Index by Author
  • Complete Issue (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on PDA Journal of Pharmaceutical Science and Technology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Considerations for the Validation of Non-CFU Based Bio-Fluorescent Particle Counting Technologies
(Your Name) has sent you a message from PDA Journal of Pharmaceutical Science and Technology
(Your Name) thought you would like to see the PDA Journal of Pharmaceutical Science and Technology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
16 + 2 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Considerations for the Validation of Non-CFU Based Bio-Fluorescent Particle Counting Technologies
Cynthia Martindale, Caroline Dreyer, Cedric Joossen, Joanny Salvas, Kim Perkins, Mike Dingle, Petra Merker, Philip Villari, Tony Cundell, Margit Franz-Riethdorf, Patrick Hutchins
PDA Journal of Pharmaceutical Science and Technology Nov 2025, 79 (6) 694-706; DOI: 10.5731/pdajpst.2024-003036.1

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Considerations for the Validation of Non-CFU Based Bio-Fluorescent Particle Counting Technologies
Cynthia Martindale, Caroline Dreyer, Cedric Joossen, Joanny Salvas, Kim Perkins, Mike Dingle, Petra Merker, Philip Villari, Tony Cundell, Margit Franz-Riethdorf, Patrick Hutchins
PDA Journal of Pharmaceutical Science and Technology Nov 2025, 79 (6) 694-706; DOI: 10.5731/pdajpst.2024-003036.1
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Background
    • Discussion
    • Conclusions
    • Conflict of Interest Declaration
    • References
  • Figures & Data
  • References
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • NIIMBL-Facilitated Active Listening Meeting between Industry and FDA Identifies Common Challenges for Adoption of Alternative and Rapid Microbiological Methods
  • PAT Implementation - Managing the Transition from Traditional Environmental Monitoring to In-Process Control of Aseptically Filled Products.
Show more Commentary

Similar Articles

Keywords

  • Alternative rapid microbial method (ARMM)
  • Bio-fluorescent particle counting (BFPC)
  • Microbiology
  • USP <1223>
  • Validation

Readers

  • About
  • Table of Content Alerts/Other Alerts
  • Subscriptions
  • Terms of Use
  • Contact Editors

Author/Reviewer Information

  • Author Resources
  • Submit Manuscript
  • Reviewers
  • Contact Editors

Parenteral Drug Association, Inc.

  • About
  • Advertising/Sponsorships
  • Events
  • PDA Bookstore
  • Press Releases

© 2026 PDA Journal of Pharmaceutical Science and Technology Print ISSN: 1079-7440  Digital ISSN: 1948-2124

Powered by HighWire